Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 6Unknown 2Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 2Urogenital Neoplasms 1Solid Neoplasm 1Sarcoma 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Hematologic Neoplasms 1Hematologic Diseases 1Health Education 1Communication 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1Adenocarcinoma of Lung 1

Interventions

pembrolizumab 25Cyclophosphamide 20Nivolumab 13Doxorubicin 13Carboplatin 10Surveys and Questionnaires 9Paclitaxel 9Exercise 9atezolizumab 8Vincristine 8Rituximab 8Radiotherapy 8Prednisone 8Dexamethasone 8Bevacizumab 8venetoclax 7fludarabine 7Pemetrexed 7Fluorouracil 7Docetaxel 7Blood Specimen Collection 7lenvatinib 6dostarlimab 6cemiplimab 6budigalimab 6Oxaliplatin 6Cisplatin 6durvalumab 5Leucovorin 5Lenalidomide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Neoplasms × Geriatric Assessment × Clear all
NCT05436327 2026-04-16

Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers

M.D. Anderson Cancer Center

Phase NA Active not recruiting
479 enrolled

Communication, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡